These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 36669581)

  • 1. Interpretable artificial neural networks for retrospective QbD of pharmaceutical tablet manufacturing based on a pilot-scale developmental dataset.
    Nagy B; Szabados-Nacsa Á; Fülöp G; Turák Nagyné A; Galata DL; Farkas A; Mészáros LA; Nagy ZK; Marosi G
    Int J Pharm; 2023 Feb; 633():122620. PubMed ID: 36669581
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Application of artificial neural networks for Process Analytical Technology-based dissolution testing.
    Nagy B; Petra D; Galata DL; Démuth B; Borbás E; Marosi G; Nagy ZK; Farkas A
    Int J Pharm; 2019 Aug; 567():118464. PubMed ID: 31252145
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Application of Artificial Neural Networks in the Process Analytical Technology of Pharmaceutical Manufacturing-a Review.
    Nagy B; Galata DL; Farkas A; Nagy ZK
    AAPS J; 2022 Jun; 24(4):74. PubMed ID: 35697951
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Convolutional neural network-based evaluation of chemical maps obtained by fast Raman imaging for prediction of tablet dissolution profiles.
    Galata DL; Zsiros B; Knyihár G; Péterfi O; Mészáros LA; Ronkay F; Nagy B; Szabó E; Nagy ZK; Farkas A
    Int J Pharm; 2023 Jun; 640():123001. PubMed ID: 37254287
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Artificial neural networks applied to quality-by-design: From formulation development to clinical outcome.
    Simões MF; Silva G; Pinto AC; Fonseca M; Silva NE; Pinto RMA; Simões S
    Eur J Pharm Biopharm; 2020 Jul; 152():282-295. PubMed ID: 32442736
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Real-time release testing of dissolution based on surrogate models developed by machine learning algorithms using NIR spectra, compression force and particle size distribution as input data.
    Galata DL; Könyves Z; Nagy B; Novák M; Mészáros LA; Szabó E; Farkas A; Marosi G; Nagy ZK
    Int J Pharm; 2021 Mar; 597():120338. PubMed ID: 33545285
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prediction of tablet weight variability in continuous manufacturing.
    Razavi SM; Scicolone J; Snee RD; Kumar A; Bertels J; Cappuyns P; Van Assche I; Cuitiño AM; Muzzio F
    Int J Pharm; 2020 Feb; 575():118727. PubMed ID: 31626923
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Minimisation of the capping tendency by tableting process optimisation with the application of artificial neural networks and fuzzy models.
    Belic A; Skrjanc I; Bozic DZ; Karba R; Vrecer F
    Eur J Pharm Biopharm; 2009 Sep; 73(1):172-8. PubMed ID: 19465122
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fast, Spectroscopy-Based Prediction of In Vitro Dissolution Profile of Extended Release Tablets Using Artificial Neural Networks.
    Galata DL; Farkas A; Könyves Z; Mészáros LA; Szabó E; Csontos I; Pálos A; Marosi G; Nagy ZK; Nagy B
    Pharmaceutics; 2019 Aug; 11(8):. PubMed ID: 31405029
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Raman-based real-time dissolution prediction using a deterministic permeation model.
    Horkovics-Kovats S; László Galata D; Zlatoš P; Nagy B; Alexandra Mészáros L; Kristóf Nagy Z
    Int J Pharm; 2022 Apr; 617():121624. PubMed ID: 35231548
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Continuous manufacturing of extended release tablets via powder mixing and direct compression.
    Ervasti T; Simonaho SP; Ketolainen J; Forsberg P; Fransson M; Wikström H; Folestad S; Lakio S; Tajarobi P; Abrahmsén-Alami S
    Int J Pharm; 2015 Nov; 495(1):290-301. PubMed ID: 26320548
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of manufacturing process variables on in vitro dissolution characteristics of extended-release tablets formulated with hydroxypropyl methylcellulose.
    Huang Y; Khanvilkar KH; Moore AD; Hilliard-Lott M
    Drug Dev Ind Pharm; 2003 Jan; 29(1):79-88. PubMed ID: 12602495
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A large-scale experimental comparison of batch and continuous technologies in pharmaceutical tablet manufacturing using ethenzamide.
    Matsunami K; Nagato T; Hasegawa K; Sugiyama H
    Int J Pharm; 2019 Mar; 559():210-219. PubMed ID: 30682448
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Spectroscopic characterization of tablet properties in a continuous powder blending and tableting process.
    Nagy B; Farkas A; Magyar K; Démuth B; Nagy ZK; Marosi G
    Eur J Pharm Sci; 2018 Oct; 123():10-19. PubMed ID: 30017844
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quantitative X-Ray Microcomputed Tomography Assessment of Internal Tablet Defects.
    Yost E; Chalus P; Zhang S; Peter S; Narang AS
    J Pharm Sci; 2019 May; 108(5):1818-1830. PubMed ID: 30639743
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Implementation of an advanced hybrid MPC-PID control system using PAT tools into a direct compaction continuous pharmaceutical tablet manufacturing pilot plant.
    Singh R; Sahay A; Karry KM; Muzzio F; Ierapetritou M; Ramachandran R
    Int J Pharm; 2014 Oct; 473(1-2):38-54. PubMed ID: 24974987
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Implementation of a fully integrated continuous manufacturing line for direct compression and coating at a commercial pharmaceutical facility - Part 1: Operational considerations and control strategy.
    Conway SL; Rosas JG; Overton P; Tugby N; Cryan P; Witulski F; Hurley S; Wareham L; Tantuccio A; Ramasamy M; Lalloo A; Gibbs M; Meyer RF
    Int J Pharm; 2023 Jul; 642():122820. PubMed ID: 37028572
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Integrating artificial and human intelligence into tablet production process.
    Gams M; Horvat M; Ožek M; Luštrek M; Gradišek A
    AAPS PharmSciTech; 2014 Dec; 15(6):1447-53. PubMed ID: 24970587
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of a continuous twin screw granulation and drying system during formulation development and process optimization.
    Vercruysse J; Peeters E; Fonteyne M; Cappuyns P; Delaet U; Van Assche I; De Beer T; Remon JP; Vervaet C
    Eur J Pharm Biopharm; 2015 Jan; 89():239-47. PubMed ID: 25528462
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Data reconciliation in the Quality-by-Design (QbD) implementation of pharmaceutical continuous tablet manufacturing.
    Su Q; Bommireddy Y; Shah Y; Ganesh S; Moreno M; Liu J; Gonzalez M; Yazdanpanah N; O'Connor T; Reklaitis GV; Nagy ZK
    Int J Pharm; 2019 May; 563():259-272. PubMed ID: 30951859
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.